News

Emma Guttman-Yassky, MD, PhD, discusses REZOLVE-AD biomarker data showing early Treg and inflammatory changes with rezpegaldesleukin from EADV 2026.

On World Psoriasis Day, advocates Nitika Chopra and Ayesha Patrick share how dermatologists can better support women of color living with visible psoriasis.

HBsAg testing becomes central to selecting patients for bepirovirsen, a finite hepatitis B therapy given alongside NA treatment.

HBsAg testing becomes central to selecting patients for bepirovirsen, a finite hepatitis B therapy given alongside NA treatment.

Patients with IPF reported less severe, less frequent cough within 2 weeks of nalbuphine ER in CORAL, with gains sustained through week 6.

Investigators will probe acid base metabolism and metabolomics to explain the blood pressure and potassium findings from DapaBalci-Leap.

David Leehey, MD, says about half of the 2376 enrolled veterans were taking an SGLT2 inhibitor at baseline.

PAES data from ASN Kidney Week 2026 show graft, patient, and kidney function outcomes at 1 year in crossmatch-positive transplants.

In the SCENARIO trial, a 15-week weight-loss program cut recurrent vascular events by 67% in patients with obesity after minor ischemic stroke or TIA.

Shannon C. Trotter, DO, and Mona Shahriari, MD, discuss burnout, people-pleasing, public speaking, and the real life behind physicians’ polished personas.

Hedayati recommends shared decision making and a 4 to 6 week treatment trial, stopping therapy when patients don’t respond.

An early behavioral activation therapy signal at 8 weeks didn’t hold, and bupropion brought more insomnia and confusion.

Retatrutide lowered A1C 2.2% vs 1.8% and cut weight 19.5%-20.9% vs 9.4% with semaglutide 2 mg at 80 weeks in adults with type 2 diabetes.

Michael Pritchett, DO, MPH, discusses real-world Ion Registry yield, sensitivity, and safety data for robotic bronchoscopy presented at CHEST 2026.

ORKA-001, a half-life extended IL-23p19 antibody, achieved PASI 100 in 61% of high-dose patients at week 16 in the phase 2b EVERLAST-B psoriasis trial.

Moshe Prero, MD, says gene therapy has changed respiratory care in SMA type 1, but residual sleep, swallowing, and spinal issues still warrant monitoring.

In interim V012 data, women on hemodialysis reached usable access months sooner with ATEV, said Prabir Roy-Chaudhury, MD, PhD.

Prabir Roy-Chaudhury, MD, PhD, explains how the ATEV is made and the research questions he wants answered next.

In PHINDER, IPF had the highest PVD-B65 mortality risk scores. Rali discusses why PH in ILD is missed and when to refer for right heart catheterization.

Parth Rali, MD, explains how the AHA/ACC A-through-E categories compare with ESC risk tiers and how hospitals can meet the class 1 PERT recommendation.

Colin Church, MBBS, PhD, discusses durable 6MWD and NT-proBNP signals in a TPIP open-label extension and what phase 3 needs to show next.

Colin Church, MBBS, PhD, discusses 24-month open-label extension data showing TPIP remains tolerable in patients with PH-ILD, with no new safety signals.

AI models have not outperformed existing clinical scores for COPD prognosis, but home monitoring may help track disease activity, Bourbeau said.

Among 117 patients, breath-hold ventilation did not improve strict diagnostic yield vs conventional (86.8% vs 92.2%) in robotic bronchoscopy.

Vanda’s oral NK-1 receptor antagonist cut any vomiting by 27% vs placebo after a single 1 mg semaglutide dose, and the company plans an sNDA submission.

This segment of Nguyen's 2026 Fall Clinical Dermatology interview highlights key insights on early dermatology career strategies and other information.

Brynn Marks, MD, MSHPEd, joins Diana Isaacs, PharmD, and Natalie Bellini, DNP, to discuss a new framework defining fully closed loop insulin delivery.

A retrospective cohort of 34,398 veterans found similar hospital days in VA and community dialysis settings across pandemic periods.